Genetron Holdings Ltd. ADR (GTH): Price and Financial Metrics Recent IPO
Genetron Holdings Ltd. ADR (GTH) Recent IPO
Today's Latest Price: $13.94 USD
Updated Dec 1 6:55pm
Add GTH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 143 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
GTH Stock Price Chart Interactive Chart >
GTH Price/Volume Stats
| Current price | $13.94 | 52-week high | $17.71 |
| Prev. close | $13.68 | 52-week low | $9.03 |
| Day low | $13.48 | Volume | 196,300 |
| Day high | $14.02 | Avg. volume | 295,898 |
| 50-day MA | $11.34 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 1.23B |
Genetron Holdings Ltd. ADR (GTH) Company Bio
Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China.
Loading social stream, please wait...